fda warning letters compounding semaglutide september 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Warns on Certain Forms
Description
GLP-1 medications have been used since 2005 to treat diabetes

Typical pricing is $15 to $25 for 30ml

This represented a significant improvement over previous obesity medications and fundamentally changed how the medical community viewed pharmacological weight management

Supporting Medical Necessity Medical necessity must align with payer policies

Nano Res
This ensures the treatment is both effective and safe
